{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T06:08:18Z","timestamp":1648879698995},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2016,5,27]],"date-time":"2016-05-27T00:00:00Z","timestamp":1464307200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s00277-016-2707-x","type":"journal-article","created":{"date-parts":[[2016,5,27]],"date-time":"2016-05-27T05:09:46Z","timestamp":1464325786000},"page":"1383-1386","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Sequential development of chronic myelogenous leukemia and primary myelofibrosis in a patient with history of large B-cell lymphoma treated with radiotherapy and chemotherapy: two myeloid neoplasms with distinct genotypic profiles suggestive of biclonality in a single individual"],"prefix":"10.1007","volume":"95","author":[{"given":"Bin","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly","family":"Ingersoll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Rehder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siby","family":"Sebastian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Endi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,5,27]]},"reference":[{"key":"2707_CR1","first-page":"3512","volume":"7","author":"L Zhang","year":"2014","unstructured":"Zhang L, Wang SA (2014) A focused review of hematopoietic neoplasms occurring in the therapy-related setting. Int J Clin Exp Pathol 7:3512\u20133523","journal-title":"Int J Clin Exp Pathol"},{"key":"2707_CR2","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1309\/AJCPYWC6AQC7BAVJ","volume":"133","author":"W Chen","year":"2010","unstructured":"Chen W, Wang E, Lu Y, Gaal KK, Huang Q (2010) Therapy-related acute lymphoblastic leukemia without 11q23 abnormality: report of six cases and a literature review. Am J Clin Pathol 133:75\u201382","journal-title":"Am J Clin Pathol"},{"key":"2707_CR3","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1038\/sj.leu.2405088","volume":"22","author":"N Cambier","year":"2008","unstructured":"Cambier N, Renneville A, Cazaentre T et al (2008) JAK2V617F-positive polycythemia vera and Philadelphia chromosome-positive chronic myeloid leukemia: one patient with two distinct myeloproliferative disorders. Leukemia 22:1454\u20131455","journal-title":"Leukemia"},{"key":"2707_CR4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3109\/10428199809058378","volume":"29","author":"RC Aguiar","year":"1998","unstructured":"Aguiar RC (1998) Therapy-related chronic myeloid leukemia: an epidemiological, clinical and pathogenetic appraisal. Leuk Lymphoma 29:17\u201326","journal-title":"Leuk Lymphoma"},{"key":"2707_CR5","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1159\/000343952","volume":"35","author":"K Zahra","year":"2012","unstructured":"Zahra K, Ben Fredj W, Ben Youssef Y et al (2012) Chronic myeloid leukemia as a secondary malignancy after lymphoma in a child. A case report and review of the literature. Onkologie 35:690\u2013693","journal-title":"Onkologie"},{"key":"2707_CR6","doi-asserted-by":"crossref","first-page":"92","DOI":"10.4274\/Tjh.2013.0180","volume":"31","author":"IS Demiriz","year":"2014","unstructured":"Demiriz IS, Tekgunduz E, Bozdag SC, Altuntas F (2014) Chronic myeloid leukemia as a secondary malignancy following treatment of diffuse large B-cell lymphoma. Turk J Haematol 31:92\u201394","journal-title":"Turk J Haematol"},{"key":"2707_CR7","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3109\/10428194.2012.692788","volume":"54","author":"XH Xu","year":"2013","unstructured":"Xu XH, Huang LS, Yang J et al (2013) Chronic myeloid leukemia arising from acute myeloid leukemia: response to imatinib mesylate with favorable outcome. Leuk Lymphoma 54:195\u2013197","journal-title":"Leuk Lymphoma"},{"key":"2707_CR8","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3904\/kjim.2014.29.2.250","volume":"29","author":"HY Lee","year":"2014","unstructured":"Lee HY, Lee KH, Hyun MS, Kim MK, Koh SA, Cho HS (2014) Chronic myeloid leukemia as a secondary malignancy after diffuse large B-cell lymphoma. Korean J Intern Med 29:250\u2013252","journal-title":"Korean J Intern Med"},{"key":"2707_CR9","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/pbc.25204","volume":"62","author":"NM Menon","year":"2015","unstructured":"Menon NM, Katsanis E, Khalpey Z, Whitlow P (2015) Pediatric secondary chronic myeloid leukemia following cardiac transplantation for anthracycline-induced cardiomyopathy. Pediatr Blood Cancer 62:166\u2013168","journal-title":"Pediatr Blood Cancer"},{"key":"2707_CR10","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1007\/s00277-011-1188-1","volume":"90","author":"JV Malfuson","year":"2011","unstructured":"Malfuson JV, Konopacki J, Fagot T et al (2011) Therapy-related myeloproliferative neoplasm with ETV6-PDGFRB rearrangement following treatment of acute promyelocytic leukemia. Ann Hematol 90:1477\u20131479","journal-title":"Ann Hematol"},{"key":"2707_CR11","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1182\/blood-2007-01-070045","volume":"110","author":"E Jabbour","year":"2007","unstructured":"Jabbour E, Kantarjian HM, Abruzzo LV et al (2007) Chromosomal abnormalities in Philadelphia chromosome negative metaphases appearing during imatinib mesylate therapy in patients with newly diagnosed chronic myeloid leukemia in chronic phase. Blood 110:2991\u20132995","journal-title":"Blood"},{"key":"2707_CR12","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1182\/blood-2006-04-017400","volume":"108","author":"C Kovitz","year":"2006","unstructured":"Kovitz C, Kantarjian H, Garcia-Manero G, Abruzzo LV, Cortes J (2006) Myelodysplastic syndromes and acute leukemia developing after imatinib mesylate therapy for chronic myeloid leukemia. Blood 108:2811\u20132813","journal-title":"Blood"},{"key":"2707_CR13","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.leukres.2005.10.015","volume":"30","author":"J Ramanarayanan","year":"2006","unstructured":"Ramanarayanan J, Dunford LM, Baer MR, Sait SN, Lawrence W, McCarthy PL (2006) Chronic myeloid leukemia after treatment of lymphoid malignancies: response to imatinib mesylate and favorable outcomes in three patients. Leuk Res 30:701\u2013705","journal-title":"Leuk Res"},{"key":"2707_CR14","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/ajh.20027","volume":"75","author":"D Waldman","year":"2004","unstructured":"Waldman D, Weintraub M, Freeman A, Neumann Y, Rechavi G, Toren A (2004) Favorable early response of secondary chronic myeloid leukemia to imatinib. Am J Hematol 75:217\u2013219","journal-title":"Am J Hematol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-016-2707-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-016-2707-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-016-2707-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T09:50:06Z","timestamp":1559037006000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-016-2707-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,27]]},"references-count":14,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["2707"],"URL":"https:\/\/doi.org\/10.1007\/s00277-016-2707-x","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,27]]}}}